Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Hadac

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 21, 2011
Myeloma xenograft destruction by a nonviral vector delivering oncolytic infectious nucleic acidElizabeth M Hadac, Elizabeth J Kelly, Stephen J Russell
Nature Medicine|October 28, 2008
Engineering microRNA responsiveness to decrease virus pathogenicityElizabeth J Kelly, Elizabeth M Hadac, Suzanne Greiner, et al.
Virology|November 3, 2004
Reengineering paramyxovirus tropismElizabeth M Hadac, Kah-Whye Peng, Takafumi Nakamura, et al.
Molecular Pharmacology|March 19, 2005
Differential spatial approximation between cholecystokinin residue 30 and receptor residues in active and inactive conformationsMaoqing Dong, Elizabeth M Hadac, Delia I Pinon, et al.
Plos Pathogens|March 25, 2010
MicroRNA antagonism of the picornaviral life cycle: alternative mechanisms of interferenceElizabeth J Kelly, Elizabeth M Hadac, Bryan R Cullen, et al.
Receptors & Channels|August 15, 2003
Disulfide bond structure and accessibility of cysteines in the ectodomain of the cholecystokinin receptor: specific mono-reactive receptor constructs examine charge-sensitivity of loop regionsXi-Qin Ding, Vesile Dolu, Elizabeth M Hadac, et al.
Journal of Virology|February 12, 2016
MicroRNA-Detargeted Mengovirus for Oncolytic VirotherapyAutumn J Ruiz, Elizabeth M Hadac, Rebecca A Nace, et al.
Journal of Medicinal Chemistry|February 3, 2006
Novel benzodiazepine photoaffinity probe stereoselectively labels a site deep within the membrane-spanning domain of the cholecystokinin receptorElizabeth M Hadac, Eric S Dawson, James W Darrow, et al.
Journal of Virological Methods|June 28, 2011
Fluorescein and radiolabeled Function-Spacer-Lipid constructs allow for simple in vitro and in vivo bioimaging of enveloped virionsElizabeth M Hadac, Mark J Federspiel, Evgeny Chernyy, et al.
AJR. American Journal of Roentgenology|December 23, 2008
Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter geneStephanie K Carlson, Kelly L Classic, Elizabeth M Hadac, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 21, 2011
Myeloma xenograft destruction by a nonviral vector delivering oncolytic infectious nucleic acidElizabeth M Hadac, Elizabeth J Kelly, Stephen J Russell
Nature Medicine|October 28, 2008
Engineering microRNA responsiveness to decrease virus pathogenicityElizabeth J Kelly, Elizabeth M Hadac, Suzanne Greiner, et al.
Virology|November 3, 2004
Reengineering paramyxovirus tropismElizabeth M Hadac, Kah-Whye Peng, Takafumi Nakamura, et al.
Molecular Pharmacology|March 19, 2005
Differential spatial approximation between cholecystokinin residue 30 and receptor residues in active and inactive conformationsMaoqing Dong, Elizabeth M Hadac, Delia I Pinon, et al.
Plos Pathogens|March 25, 2010
MicroRNA antagonism of the picornaviral life cycle: alternative mechanisms of interferenceElizabeth J Kelly, Elizabeth M Hadac, Bryan R Cullen, et al.
Receptors & Channels|August 15, 2003
Disulfide bond structure and accessibility of cysteines in the ectodomain of the cholecystokinin receptor: specific mono-reactive receptor constructs examine charge-sensitivity of loop regionsXi-Qin Ding, Vesile Dolu, Elizabeth M Hadac, et al.
Journal of Virology|February 12, 2016
MicroRNA-Detargeted Mengovirus for Oncolytic VirotherapyAutumn J Ruiz, Elizabeth M Hadac, Rebecca A Nace, et al.
Journal of Medicinal Chemistry|February 3, 2006
Novel benzodiazepine photoaffinity probe stereoselectively labels a site deep within the membrane-spanning domain of the cholecystokinin receptorElizabeth M Hadac, Eric S Dawson, James W Darrow, et al.
Journal of Virological Methods|June 28, 2011
Fluorescein and radiolabeled Function-Spacer-Lipid constructs allow for simple in vitro and in vivo bioimaging of enveloped virionsElizabeth M Hadac, Mark J Federspiel, Evgeny Chernyy, et al.
AJR. American Journal of Roentgenology|December 23, 2008
Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter geneStephanie K Carlson, Kelly L Classic, Elizabeth M Hadac, et al.
Pageof 2